Danielle Marie Brander, MD

Assistant Professor of Medicine
Member of the Duke Cancer Institute
Campus mail 2400 Pratt St Suite 5000, Durham, NC 27710
Phone (919) 668-1000
Email address danielle.brander@duke.edu
In Their Words

Education and Training

  • Resident, Internal Medicine, Duke University School of Medicine, 2007 - 2010
  • M.D., Duke University School of Medicine, 2007

Grants

Publications

Hu, Rachel, Wei Wei, Agrima Mian, Kristen Gonter-Aubin, Charlene Kabel, Anthony Mato, Deborah M. Stephens, et al. “Treatment outcomes with purine nucleoside analog alone or with rituximab for hairy cell leukemia at first relapse.” Eur J Haematol 108, no. 5 (May 2022): 379–82. https://doi.org/10.1111/ejh.13744.

PMID
35043475
Full Text

Mato, Anthony R., Matthew S. Davids, Jeff Sharman, Lindsey E. Roeker, Neil Kay, Arnon P. Kater, Kerry Rogers, et al. “Recognizing Unmet Need in the Era of Targeted Therapy for CLL/SLL: "What's Past Is Prologue" (Shakespeare).” Clin Cancer Res 28, no. 4 (February 15, 2022): 603–8. https://doi.org/10.1158/1078-0432.CCR-21-1237.

PMID
34789482
Full Text

Kleinstern, Geffen, J Brice Weinberg, Sameer A. Parikh, Esteban Braggio, Sara J. Achenbach, Dennis P. Robinson, Aaron D. Norman, et al. “Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African Americans.” Leukemia 36, no. 1 (January 2022): 119–25. https://doi.org/10.1038/s41375-021-01344-9.

PMID
34285341
Full Text

Davids, Matthew S., Owen A. O’Connor, Wojciech Jurczak, Felipe Samaniego, Timothy S. Fenske, Pier Luigi Zinzani, Manish R. Patel, et al. “Integrated safety analysis of umbralisib, a dual PI3Kδ/CK1ε inhibitor, in relapsed/refractory lymphoid malignancies.” Blood Adv 5, no. 23 (December 14, 2021): 5332–43. https://doi.org/10.1182/bloodadvances.2021005132.

PMID
34547767
Full Text

MacDonald, Grace, Andrea Sitlinger, Michael A. Deal, Erik D. Hanson, Stephanie Ferraro, Carl F. Pieper, J Brice Weinberg, Danielle M. Brander, and David B. Bartlett. “A pilot study of high-intensity interval training in older adults with treatment naïve chronic lymphocytic leukemia.” Sci Rep 11, no. 1 (November 30, 2021): 23137. https://doi.org/10.1038/s41598-021-02352-6.

PMID
34848750
Full Text

Stephens, Deborah M., Ken Boucher, Elizabeth Kander, Sameer A. Parikh, Erin M. Parry, Mazyar Shadman, John M. Pagel, et al. “Hodgkin lymphoma arising in patients with chronic lymphocytic leukemia: outcomes from a large multi-center collaboration.” Haematologica 106, no. 11 (November 1, 2021): 2845–52. https://doi.org/10.3324/haematol.2020.256388.

PMID
33054118
Full Text

Ruppert, Amy S., Allison M. Booth, Wei Ding, Nancy L. Bartlett, Danielle M. Brander, Steven Coutre, Jennifer R. Brown, et al. “Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202.” Leukemia 35, no. 10 (October 2021): 2854–61. https://doi.org/10.1038/s41375-021-01342-x.

PMID
34274940
Full Text

Ma, Shuo, John F. Seymour, Danielle M. Brander, Thomas J. Kipps, Michael Y. Choi, Mary Ann Anderson, Kathryn Humphrey, et al. “Efficacy of venetoclax plus rituximab for relapsed CLL: 5-year follow-up of continuous or limited- duration therapy.” Blood 138, no. 10 (September 9, 2021): 836–46. https://doi.org/10.1182/blood.2020009578.

PMID
34115103
Full Text

Gordon, Max J., Andy Kaempf, Andrea Sitlinger, Geoffrey Shouse, Matthew Mei, Danielle M. Brander, Tareq Salous, et al. “The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI): A Three-Factor Comorbidity Model.” Clin Cancer Res 27, no. 17 (September 1, 2021): 4814–24. https://doi.org/10.1158/1078-0432.CCR-20-3993.

PMID
34168050
Full Text

Mato, Anthony R., Nilanjan Ghosh, Stephen J. Schuster, Nicole Lamanna, John M. Pagel, Ian W. Flinn, Jacqueline C. Barrientos, et al. “Phase 2 study of the safety and efficacy of umbralisib in patients with CLL who are intolerant to BTK or PI3Kδ inhibitor therapy.” Blood 137, no. 20 (May 20, 2021): 2817–26. https://doi.org/10.1182/blood.2020007376.

PMID
33259589
Full Text

Pages